Evotec SE
EVT.DE$1.12B
Small CapXETRABiotechnology🇺🇸North America4.8K employees
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EVT.DE News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
EVT 302, 10 mg
Smoking Cessation
EVT 302
Smoking Cessation
EVT 201
Sleep Initiation and Maintenance Disorders
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
EVT 302, 10 mg | Phase 2 | Smoking Cessation | - | - |
EVT 302 | Phase 2 | Smoking Cessation | - | - |
EVT 201 | Phase 2 | Sleep Initiation and Maintenance Disorders | - | - |
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply